Stock market today: S&P 500 climbs as health care, tech gain; Nvidia earnings loom
Today, Haleon plc (LSE/NYSE:HLN) reported a transaction involving its Chief Corporate Affairs Officer, Ed Petter, according to a statement based on a press release. The disclosure aligns with the UK Market Abuse Regulation requirements for transactions by Persons Discharging Managerial Responsibilities (PDMRs).
On June 2, 2025, Petter received the vesting of the first tranche of an award of Haleon Ordinary Shares under the Haleon Share Value Plan. This award was part of his remuneration package upon joining Haleon, serving as compensation for incentives forfeited from his previous employment. The award includes provisions for malus and clawback.
The transaction involved the acquisition of 51,584 Ordinary Shares at a price of £0.01 each, with a volume of shares acquired at no cost. Additionally, an automatic disposal of shares occurred to cover tax liabilities, involving 24,305 shares at a price of £4.134623 each. The disposal took place on the London Stock Exchange (LON:LSEG) (XLON).
Haleon, a leader in consumer health, operates in six major categories, including oral health and pain relief, with well-known brands such as Advil and Sensodyne.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.